In response to COVID-19, the activation of ECs was also associated with the overexpression of proangiogenic factors, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (FGF-2), and placental growth factors (PlGF; Smadja et al., 2021). Here, PGF is linked to COVID-19.